The use of pegylated liposomal doxorubicin in metastatic soft tissue sarcoma
Background: Soft tissue sarcoma (STS) is a heterogeneous group of rare malignancies with limited response to conventional chemotherapy. Among these, epithelioid haemangioendothelioma (EHE) and angiosarcoma represent rare vascular sarcomas with distinct clinical behaviours, challenging treatment appr...
Saved in:
| Main Authors: | Trang Pham, Hanne Krogh Rose, Philip Rossen, Ninna Aggerholm Pedersen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical Journals Sweden
2025-04-01
|
| Series: | Acta Oncologica |
| Subjects: | |
| Online Access: | https://medicaljournalssweden.se/actaoncologica/article/view/43263 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phase I Trial of Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Advanced Soft Tissue Sarcoma
by: Ye T, et al.
Published: (2025-08-01) -
Gemcitabine Plus Docetaxel, Dacarbazine, Doxorubicin Combinations, or Doxorubicin Alone as First-Line Treatment for Advanced/Metastatic Leiomyosarcoma: A Retrospective Analysis at a Sarcoma Center
by: Ted Kim, et al.
Published: (2025-03-01) -
Place of pegylated liposomal doxorubicin in the therapy of metastatic breast cancer
by: E. V. Artamonova
Published: (2016-09-01) -
Unveiling the Uncommon: Ewing Sarcoma Cranium - A Rare Clinical Vignette
by: Kavya Sharma, et al.
Published: (2025-04-01) -
Survival prognostic factors and molecular aspects in extremity soft tissue sarcoma
by: Bogdan Serban, et al.
Published: (2024-10-01)